Indian pharma headwinds to see subside in FY24: ICRA

Rating agency ICRA said it expects the revenues of its sample set of 25 Indian pharmaceutical companies which account for 60% of the overall Indian pharmaceutical industry to grow by 7-9% in FY24.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/jgQUd2A
via IFTTT